Tyra Biosciences stockholders elect three Class I directors and ratify EY as auditor

Tyra Biosciences, Inc.

Todd Harris, Adele Gulfo, and S. Michael Rothenberg elected as Class I directors for three-year terms.
Harris received 33,878,966 for and 6,434,333 withheld; Gulfo 40,310,667 for and 2,632 withheld; Rothenberg 33,731,963 for and 6,581,336 withheld.
Ratification of Ernst & Young as auditor for FY2025: 45,356,001 for, 235 against, 643 abstain; no broker non-votes.
Broker non-votes on director election totaled 5,043,580 for each director.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.